Latest ovarian cancer News | Page 4

Anna Boltong Appointed As Ovarian Cancer Australia CEO
Important workers compensation reforms supporting fire-fighters pass Parliament
WINNERS: 2023 Nike Melbourne Marathon Festival
Manchester scientists investigate how to stop a more aggressive form of breast cancer spreading
Starpharma announces the presentation of DEP irinotecan combination data
Compound d16 reduces tumor growth and overcomes therapeutic resistance in mutant p53-bearing cancers
Combination of personalized cancer vaccine and adoptive T cell therapy benefits patients with advanced ovarian cancer
Tests that diagnose diseases are less reliable than you’d expect. Here’s why
Progressing nation-leading reforms for our firefighters
Mater Research’s Future Leaders Celebrated at Annual Symposium
Leading the way in health and safety for Tasmania’s fire-fighters
6 things to know about ovarian cancer
Law reform agenda strong as Government prepares for Parliament’s return
Ovarian cancer patient plans wedding in hospital
Melbourne team on the verge of a more accurate test for ovarian cancer
Can the body’s signalling protein be harnessed to stop ovarian cancer?
Greens introduce bill to expand presumptive cancer scheme for Victorian firefighters
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Mater revolutionises hysterectomy surgery for women
Early-Stage Innovation Forum opens
Study improves accuracy of predictive breast cancer genetic test for Ashkenazi Jewish women
Sculpture soars in memory of Maureen Nathan
Acceptance is a big thing – you’ve got to accept what’s happening to you to move forward   
Firefighter cancer scheme would be expanded under Greens’ bill
Lynparza and Imfinzi combination reduced risk of disease progression or death by 37% vs. chemotherapy and bevacizumab in patients with advanced ovarian…
Major development for cancer-killing ‘Masterswitch’ discovery
Best early-stage project at awarded at AusMedtech 2023
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
CUREator funds Hudson Institute biotech innovation
When facing ovarian cancer, Susan Catton saw an opportunity to help others
World Ovarian Cancer Day: Personalising treatment for women with ovarian cancer 
Study shows benefit of universal genetic testing after breast cancer diagnosis
Q1 2023 results
First patient on trial in colorectal, gastric and ovarian cancer study
Two Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
AstraZeneca advances its pipeline and highlights progress in immuno-oncology, ADCs, cell therapy and epigenetics at AACR
Social solution – rare ovarian cancer insights
Lynparza and Imfinzi combination improved progression-free survival in newly diagnosed patients with advanced ovarian cancer without tumour BRCA mutations in DUO-O Phase III trial
Leading way in care for our firefighters
Orkney cancer gene link revealed
$7.5 million in grants for medical research
Sarah Adam-Gedge Joins CA Board
Southern Hemisphere’s largest lab opens in Melbourne’s west
Funding boost for research into deadly cancers affecting women
Faster genetic tests give hope to ovarian cancer patients
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
Brave Queensland mum celebrates miracle babies despite ovarian cancer
Microcalcification ‘fingerprints’ can yield info about cancer